Approval · Notice of Compliance 12833 · 2011
SULCRATE: Notice of Compliance 12833
Issued November 29, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12833
- Date
- November 29, 2011
- Company
- Aptalis Pharma Canada UlcMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer Name Change
- Therapeutic class
- Gastro-duodenal Cytoprotective Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SULCRATE | 02100622 | Marketed |
| SULCRATE SUSPENSION PLUS | 02103567 | Marketed |
Medicinal ingredients
- SUCRALFATE 1 G per TAB
- SUCRALFATE 1 G per 5ML